MED12 and leiomyoma: All of the uterine leiomyosarcoma specimens that were clustered into the leiomyoma group were included in SC2, indicating that the DNA methylation profiles of the marker genes are similar to the marker gene profiles of uterine leiomyomas without MED12 mutations.